Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
66.76
+0.60 (0.91%)
At close: Apr 19, 2024, 4:00 PM
66.66
-0.10 (-0.15%)
After-hours: Apr 19, 2024, 7:59 PM EDT
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of $83.25 billion as of April 19, 2024. Its market cap has decreased by -18.75% in one year.
Market Cap
83.25B
Enterprise Value
100.53B
1-Year Change
-18.75%
Ranking
Category
Stock Price
$66.76
Market Cap Chart
Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $83.25B, an increase of 8,454.90%. That is a compound annual growth rate of 19.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 82.42B | -1.15% |
| Apr 17, 2024 | 83.38B | -0.56% |
| Apr 16, 2024 | 83.85B | -0.65% |
| Apr 15, 2024 | 84.40B | -0.47% |
| Apr 12, 2024 | 84.80B | -0.84% |
| Apr 11, 2024 | 85.52B | 0.78% |
| Apr 10, 2024 | 84.86B | -2.60% |
| Apr 9, 2024 | 87.13B | 0.75% |
| Apr 8, 2024 | 86.48B | -0.23% |
| Apr 5, 2024 | 86.68B | 0.04% |
| Apr 4, 2024 | 86.64B | -1.89% |
| Apr 3, 2024 | 88.31B | -1.66% |
| Apr 2, 2024 | 89.81B | -1.08% |
| Apr 1, 2024 | 90.79B | -0.51% |
| Mar 28, 2024 | 91.25B | 0.33% |
| Mar 27, 2024 | 90.95B | 0.83% |
| Mar 26, 2024 | 90.21B | -0.23% |
| Mar 25, 2024 | 90.42B | -0.04% |
| Mar 22, 2024 | 90.46B | -0.66% |
| Mar 21, 2024 | 91.05B | -1.20% |
| Mar 20, 2024 | 92.16B | 0.78% |
| Mar 19, 2024 | 91.45B | 0.20% |
| Mar 18, 2024 | 91.27B | -0.58% |
| Mar 15, 2024 | 91.80B | -0.70% |
| Mar 14, 2024 | 92.45B | -2.28% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boston Scientific | 99.89B |
| Cigna | 98.16B |
| Regeneron Pharmaceuticals | 97.28B |
| Bristol-Myers Squibb Company | 96.96B |
| CVS Health | 86.33B |
| HCA Healthcare | 82.26B |
| GSK | 80.35B |
| Zoetis | 69.57B |